Literature DB >> 4933875

Emergence of resistant organisms as a function of dose in oxolinic acid therapy.

H Clark, N K Brown, J F Wallace, M Turck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4933875     DOI： 10.1097/00000441-197103000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  4 in total

1.  Bioevaluation of the antibacterial flumequine for urinary tract use.

Authors:  S R Rohlfing; J R Gerster; D C Kvam
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

2.  Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.

Authors:  D Greenwood
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

3.  In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.

Authors:  D L Shungu; E Weinberg; H H Gadebusch
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

4.  Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies.

Authors:  Ana-Madalina Maciuca; Alexandra-Cristina Munteanu; Mirela Mihaila; Mihaela Badea; Rodica Olar; George Mihai Nitulescu; Cristian V A Munteanu; Marinela Bostan; Valentina Uivarosi
Journal:  Molecules       Date:  2020-11-19       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.